Joan Lo to Aged, 80 and over
This is a "connection" page, showing publications Joan Lo has written about Aged, 80 and over.
Connection Strength
2.342
-
Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system. Osteoporos Int. 2025 Apr; 36(4):741-747.
Score: 0.162
-
Examining Whether Patient Portal and Video Visit Use Differs by Race and Ethnicity Among Older Adults in a US Integrated Health Care Delivery System: Cross-Sectional Electronic Health Record and Survey-Based Study. JMIR Aging. 2024 Nov 07; 7:e63814.
Score: 0.160
-
Prevalence of low vitamin D levels among older US Asian and Pacific Islander adults. Osteoporos Int. 2024 Nov; 35(11):2017-2024.
Score: 0.158
-
Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy. JAMA Netw Open. 2021 11 01; 4(11):e2133861.
Score: 0.130
-
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020 Dec 03; 21(1):801.
Score: 0.122
-
The Epidemiology of Metatarsal Fractures Among Older Females With Bisphosphonate Exposure. J Foot Ankle Surg. 2020 Mar - Apr; 59(2):269-273.
Score: 0.115
-
Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study. BMC Public Health. 2019 Nov 25; 19(1):1551.
Score: 0.113
-
Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
Score: 0.112
-
Vitamin D Status Among Older Women Initiating Osteoporosis Therapy. J Am Geriatr Soc. 2019 10; 67(10):2207-2208.
Score: 0.111
-
Predicting Adherence and Persistence with Oral Bisphosphonate Therapy in an Integrated Health Care Delivery System. J Manag Care Spec Pharm. 2017 Apr; 23(4):503-512.
Score: 0.094
-
Mortality following hip fracture in Chinese, Japanese, and Filipina women. Am J Manag Care. 2016 Oct 01; 22(10):e358-e359.
Score: 0.091
-
Trends in mortality following hip fracture in older women. Am J Manag Care. 2015 Mar 01; 21(3):e206-14.
Score: 0.082
-
Racial/ethnic differences in hip and diaphyseal femur fractures. Osteoporos Int. 2014 Sep; 25(9):2313-8.
Score: 0.078
-
Healthcare utilization of bereaved family members following the 1999 Chi-chi earthquake: evidence from administrative data. J Psychosom Res. 2013 Nov; 75(5):484-90.
Score: 0.074
-
Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. J Oral Maxillofac Surg. 2012 Aug; 70(8):1844-53.
Score: 0.067
-
Clinical correlates of atypical femoral fracture. Bone. 2012 Jul; 51(1):181-4.
Score: 0.066
-
The impact of subtrochanteric fracture criteria on hip fracture classification. Osteoporos Int. 2012 Feb; 23(2):743-50.
Score: 0.063
-
Fracture risk tool validation in an integrated healthcare delivery system. Am J Manag Care. 2011 Mar; 17(3):188-94.
Score: 0.062
-
Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89.
Score: 0.044
-
The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs). Osteoporos Int. 2025 Mar; 36(3):539-546.
Score: 0.041
-
Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
Score: 0.035
-
Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
Score: 0.032
-
Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women. JAMA Netw Open. 2020 12 01; 3(12):e2025190.
Score: 0.030
-
Determinants of Oral Bisphosphonate Use Beyond 5 Years. J Manag Care Spec Pharm. 2020 Feb; 26(2):197-202.
Score: 0.029
-
Identifying Key Risk Factors for Dizziness Handicap in Middle-Aged and Older People. J Am Med Dir Assoc. 2020 03; 21(3):344-350.e2.
Score: 0.028
-
The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019 Feb; 30(2):187-193.
Score: 0.027
-
Reducing the burden of dizziness in middle-aged and older people: A multifactorial, tailored, single-blind randomized controlled trial. PLoS Med. 2018 07; 15(7):e1002620.
Score: 0.026
-
Racial-Ethnic Differences in Fall Prevalence among Older Women: A Cross-Sectional Survey Study. BMC Geriatr. 2017 03 11; 17(1):65.
Score: 0.023
-
A multidisciplinary intervention to prevent subsequent falls and health service use following fall-related paramedic care: a randomised controlled trial. Age Ageing. 2017 03 01; 46(2):200-207.
Score: 0.023
-
Tailored multifactorial intervention to improve dizziness symptoms and quality of life, balance and gait in dizziness sufferers aged over 50 years: protocol for a randomised controlled trial. BMC Geriatr. 2017 02 15; 17(1):56.
Score: 0.023
-
Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat. 2017 02; 161(3):501-513.
Score: 0.023
-
Effects of nonslip socks on the gait patterns of older people when walking on a slippery surface. J Am Podiatr Med Assoc. 2013 Nov-Dec; 103(6):471-9.
Score: 0.019
-
Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
Score: 0.018
-
The effect of lower limb muscle fatigue on obstacle negotiation during walking in older adults. Gait Posture. 2013 Apr; 37(4):506-10.
Score: 0.017
-
Treatment of vitamin D deficiency within a large integrated health care delivery system. J Manag Care Pharm. 2012 Sep; 18(7):497-505.
Score: 0.017
-
Methods for assessing fracture risk prediction models: experience with FRAX in a large integrated health care delivery system. J Clin Densitom. 2011 Oct-Dec; 14(4):407-15.
Score: 0.016
-
Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
Score: 0.011